ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

Clinical trial NCT04055649 · RECRUITING

Trial details

NCT number: NCT04055649
Sponsor: Ira Winer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Ovarian Epithelial Tumor Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Ovarian Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Refractory Fallopian Tube Carcinoma Refractory Ovarian Carcinoma Refractory Primary Peritoneal Carcinoma

Start date: 2020-01-21
Primary completion: 2027-05-28
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.